Abstract
This study aimed to investigate the effect of a novel kind of immune-stimulating complexes (ISCOMs) on human skin penetration of model compounds in vitro to evaluate their potential as a delivery system, ultimately for transcutaneous vaccination. Special focus was on elucidating the mechanisms of penetration. Preparation of ISCOMs was done by dialysis and subsequent purification in a sucrose density gradient. The penetration pathways of acridine-labeled ISCOMs were visualized using confocal laser scanning microscopy (CLSM). Transmission electron microscopy (TEM) was used to evaluate the ultrastructural changes in the skin after application of the ISCOMs with or without hydration. Transcutaneous permeation of the model compound, methyl nicotinate, was evaluated in diffusion cells. The prepared ISCOMs were 42–52 nm in diameter as evaluated by dynamic light scattering with zeta potentials of −33 to −26.1 mV. TEM investigations verified the presence of ISCOM structures. Penetration of acridine into skin was greatly increased by incorporation into ISCOMs as visualized by CLSM. Permeation of methyl nicotinate was enhanced in the presence of ISCOMs. Ultrastructural changes of the intercellular space in the stratum corneum after exposure of ISCOMs were observed on micrographs, especially for hydrated skin. In conclusion, cutaneous application of ISCOMs leads to increased penetration of hydrophobic model compounds through human stratum corneum and thus shows potential as a transcutaneous delivery system. The increased penetration seems to be reflected by a change in the intercellular space between the corneocytes, and the effect is most likely caused by the components of the ISCOMs rather than intact ISCOMs.
Similar content being viewed by others
Abbreviations
- APC:
-
Antigen-presenting cells
- CLSM:
-
Confocal laser scanning microscopy
- DLS:
-
Dynamic light scattering
- ISCOMs:
-
Immune-stimulating complexes
- LDE:
-
Laser Doppler electrophoresis
- TEM:
-
Transmission electron microscopy
- UC:
-
Ultracentrifugation
References
Barr IG, Mitchell GF. ISCOMs (immunostimulating complexes): the first decade. Immunol Cell Biol. 1996;74:8–25.
Sanders MT, Brown LE, Deliyannis G, Pearse MJ. ISCOM-based vaccines: the second decade. Immunol Cell Biol. 2005;83:119–28.
Lendemans DG, Myschik J, Hook S, Rades T. Cationic cage-like complexes formed by DC-cholesterol, Quil-A, and phospholipid. J Pharm Sci. 2005;94:1794–807.
McBurney WT, Lendemans DG, Myschik J, Hennessy T, Rades T, Hook S. In vivo activity of cationic immune stimulating complexes (PLUSCOMs). Vaccine. 2008;26:4549–56.
Huang CM. Topical vaccination: the skin as a unique portal to adaptive immune responses. Semin Immunopathol. 2007;29:71–80.
Zaba LC, Krueger JG, Lowes MA. Resident and “inflammatory” dendritic cells in human skin. J Invest Dermatol. 2009;129:302–8.
Kirkby N, Samuelsen P (inventors). Composition for vaccination. PCT No. PCT/DK03/00654; 2006 Jul 6.
Madsen HB, Rozlosnik N, Manniche S, Madsen F, Nielsen HM, Ifversen P. http://www.aapsj.org/abstracts/AM_2007/AAPS2007-001115.PDF. Accessed 22 April 2007.
Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci. 2006;91:159–65.
varez-Roman R, Naik A, Kalia YN, Fessi H, Guy RH. Visualization of skin penetration using confocal laser scanning microscopy. Eur J Pharm Biopharm. 2004;58:301–16.
van den Bergh BA, Vroom J, Gerritsen H, Junginger HE, Bouwstra JA. Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. Biochim Biophys Acta. 1999;1461:155–73.
Cevc G, Schatzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta. 2002;1564:21–30.
van den Bergh BA, Bouwstra JA, Junginger HE, Wertz PW. Elasticity of vesicles affects hairless mouse skin structure and permeability. J Control Release. 1999;62:367–79.
Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, Lopez-Quintela MA. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol. 2007;127:1701–12.
Fatouros DG, Groenink HW, de Graaff AM, van Aelst AC, Koerten HK, Bouwstra JA. Visualization studies of human skin in vitro/in vivo under the influence of an electrical field. Eur J Pharm Sci. 2006;29:160–70.
Bhatia KS, Singh J. Effect of linolenic acid/ethanol or limonene/ethanol and iontophoresis on the in vitro percutaneous absorption of LHRH and ultrastructure of human epidermis. Int J Pharm. 1999;180:235–50.
Hoglund S, Dalsgaard K, Lovgren K, Sundquist B, Osterhaus A, Morein B. ISCOMs and immunostimulation with viral antigens. Subcell Biochem. 1989;15:39–68.
Baxter-Gabbard KL. A simple method for the large-scale preparation of sucrose gradients. FEBS Lett. 1972;20:117–9.
Myschik J, Lendemans DG, McBurney WT, Demana PH, Hook S, Rades T. On the preparation, microscopic investigation and application of ISCOMs. Micron. 2006;37:724–34.
Demana PH, Davies NM, Berger B, Vosgerau U, Rades T. A comparison of pseudo-ternary diagrams of aqueous mixtures of Quil A, cholesterol and phospholipid prepared by lipid-film hydration and dialysis. J Pharm Pharmacol. 2004;56:573–80.
Bouwstra JA, Honeywell-Nguyen PL. Skin structure and mode of action of vesicles. Adv Drug Deliv Rev. 2002;54:S41–55.
Potts RO, Guy RH. Predicting skin permeability. Pharm Res. 1992;9:663–9.
Dubey V, Mishra D, Nahar M, Jain NK. Elastic liposomes mediated transdermal delivery of an anti-jet lag agent: preparation, characterization and in vitro human skin transport study. Curr Drug Deliv. 2008;5:199–206.
Zhang LW, Yu WW, Colvin VL, Monteiro-Riviere NA. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol Appl Pharmacol. 2008;228:200–11.
Muhammad F, Monteiro-Riviere NA, Riviere JE. Comparative in vivo toxicity of topical JP-8 jet fuel and its individual hydrocarbon components: identification of tridecane and tetradecane as key constituents responsible for dermal irritation. Toxicol Pathol. 2005;33:258–66.
Monteiro-Riviere NA, Inman AO, Mak V, Wertz P, Riviere JE. Effect of selective lipid extraction from different body regions on epidermal barrier function. Pharm Res. 2001;18:992–8.
Swartzendruber DC, Wertz PW, Kitko DJ, Madison KC, Downing DT. Molecular models of the intercellular lipid lamellae in mammalian stratum corneum. J Invest Dermatol. 1989;92:251–7.
van den Bergh BA, Swartzendruber DC, Bos-Van der GA, Hoogstraate JJ, Schrijvers AH, Bodde HE, et al. Development of an optimal protocol for the ultrastructural examination of skin by transmission electron microscopy. J Microsc. 1997;187:125–33.
Swartzendruber DC, Burnett IH, Wertz PW, Madison KC, Squier CA. Osmium tetroxide and ruthenium tetroxide are complementary reagents for the preparation of epidermal samples for transmission electron microscopy. J Invest Dermatol. 1995;104:417–20.
Schreier H, Bouwstra J. Liposomes and niosomes as topical drug carriers—dermal and transdermal drug-delivery. J Control Release. 1994;30:1–15.
Honeywell-Nguyen PL, Bouwstra JA. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today. 2005;2:67–74.
Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1992;1104:226–32.
Recchia J, Lurantos MH, Amsden JA, Storey J, Kensil CR. A semisynthetic Quillaja saponin as a drug delivery agent for aminoglycoside antibiotics. Pharm Res. 1995;12:1917–23.
Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2004;56:603–18.
Aungst BJ, Rogers NJ, Shefter E. Enhancement of naloxone penetration through human-skin in vitro using fatty-acids, fatty alcohols, surfactants, sulfoxides and amides. Int J Pharm. 1986;33:225–34.
Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;11:1261–8.
Acknowledgements
This study was financially supported by the Danish National Advanced Technology Foundation and the Drug Research Academy. Karina Juul Vissing is acknowledged for technical assistance and Niels Coley for linguistic revision of the manuscript. Nordic vaccine A/S is greatly acknowledged for their kind sharing of know-how on the preparation and characterization of the Posintro™ nanoparticles and for their helpful discussions. Furthermore, Nancy Monteiro-Riviere and Al Inman are acknowledged for their kind help on TEM studies with ruthenium tetroxide.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Madsen, H.B., Ifversen, P., Madsen, F. et al. In Vitro Cutaneous Application of ISCOMs on Human Skin Enhances Delivery of Hydrophobic Model Compounds Through the Stratum Corneum. AAPS J 11, 728–739 (2009). https://doi.org/10.1208/s12248-009-9149-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12248-009-9149-5